- Published at
- by manilatimes.net
mixed
mixed
News for Cidara Therapeutics, Inc. (CDTX)
- Published at
- by gurufocus.com
mixedmixedCidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer
Industry veteran CFO Frank Karbe brings more than 25 years of leadership experience in the biopharma industry transitioning companies from R&D to commercializa- Published at
- by gurufocus.com
positivepositiveBiotechnology Value Fund L P Increases Stake in Cidara Therapeutics Inc
On December 31, 2024, Biotechnology Value Fund L P made a significant move by increasing its stake in Cidara Therapeutics Inc (CDTX). The firm added 390,373 sha- Published at
- by seekingalpha.com
neutralneutralBullish On Cidara As It Doubles Down On CD388 For Universal Flu Prevention (NASDAQ:CDTX)
Cidara Therapeutics is leveraging its Cloudbreak platform to develop CD388 for universal influenza prophylaxis. See why I rate CDTX stock a speculative buy.- Published at
- by insidermonkey.com
neutralneutralHere’s Why Cidara Therapeutics, Inc. (CDTX) Is Skyrocketing
One of the strongest stock market anomalies is the momentum effect, which is the tendency of recent past winners to outperform the recent past losers.- Published at
- by rttnews.com
neutralneutralCidara's Phase II Trial Testing CD388 For Flu Prevention Fully Enrolled With 5,000 Subjects
Cidara Therapeutics, Inc. (CDTX), a biotechnology company, today, announced it has completed enrollment in its phase IIb NAVIGATE trial of CD388 for seasonal influenza prevention.- Published at
- by manilatimes.net
positivepositive- Published at
- by gurufocus.com
positivepositiveCidara Therapeutics Completes Enrollment of Phase 2b NAVIGATE Trial Evaluating CD388 for Prevention of Seasonal Influenza
SAN DIEGO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. ( CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop- Published at
- by zacks.com
neutralneutralCidara Therapeutics (CDTX) Just Flashed Golden Cross Signal: Do You Buy?
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?- Published at
- by gurufocus.com
positivepositiveRA CAPITAL MANAGEMENT, L.P. Increases Stake in Cidara Therapeutics Inc
On November 26, 2024, RA CAPITAL MANAGEMENT, L.P. (Trades, Portfolio) executed a significant transaction involving Cidara Therapeutics Inc (CDTX). The firm adde- Published at
- by seekingalpha.com
positivepositiveCidara: Potential To Change Flu Prophylaxis Landscape With CD388
Exciting developments in flu treatment with CD388 prophylaxis and potential anti-CD73 inhibitor for Triple-Negative breast cancer on the horizon. Click to read.- Published at
- by gurufocus.com
positivepositiveCidara Therapeutics Announces $105 Million Private Placement
Financing led by new investor, Venrock Healthcare Capital Partners, with significant participation by new and existing life sciences-focused investors SAN DIE- Published at
- by seekingalpha.com
mixedmixedQuince Therapeutics: High-Potential Turnaround With Phase 3 Asset EryDex (NASDAQ:QNCX)
Quince’s transformation is complete with the acquisition of EryDel in October 2023. Check out the reasons why I rate QNCX stock as a Strong Buy.- Published at
- by benzinga.com
mixedmixedWhy Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - ReAlpha Tech Corp (NASDAQ:AIRE), Ascent Solar Technologies (NASDAQ:ASTI)
Loading... Loading... Shares of Teradyne, Inc. TER rose sharply in today's pre-market trading after the company posted upbeat first-quarter results and issued ...- Published at
- by benzinga.com
mixedmixedWhy Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Abeona Therapeutics (NASDAQ:ABEO), Anitra (AMEX:AZTR)
Loading... Loading... Shares of Nucor Corporation NUE fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial ...TTOOTIRXSSLSPOTN.MXSPOTD.BASPOT.BASPOTSPCE.MXSPCESOLBE1.JOSOL.JOSASOFS1PO34.SARPALIOPRTNUE.MXNUE.BANUEN1UE34.SAMSB.AXMESOMEOBFJFUJAGXHSTMFCELBFCEL.MXFCELCDTXCANCALX639.DE0SPT.L0K9L.L0A60.L0A57.LXRXB34.SAXRXSPCBKULRJBLU.MXJBLUJAW.DECLF.MXCLFCHCIBE0JOT.L0I0H.L0A6Y.L0A4L.LSSDROKU.MXROKUPHIOWPHIOMSCI.MXMSCIM1SC34.SALKQL1KQ34.SAHRTXABEO3HM.DE0KXI.L0JSJ.L0J4V.L0H7R.L0A8Y.L- Published at
- by benzinga.com
mixedmixedWhy Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Abeona Therapeutics (NASDAQ:ABEO), AGBA Group Holding (NASDAQ:AGBA)
Loading... Loading... Shares of Hibbett, Inc. HIBB rose sharply in today's pre-market trading after the company agreed to be acquired by JD Sports Fashion for ...- Published at
- by marketscreener.com
mixedmixed- Published at
- by investing.com
mixedmixedU.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.00% By Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.00%- Published at
- by benzinga.com
mixedmixed83 Biggest Movers From Yesterday
Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly traded company.YQXCURVVPRVRYYFVERY.VVERY.CNTTNPWTTNPTLSATGTXTBLTTALN.MXTALSVFAWSVFAUSVFASRAXSQFLSNMPSMDMSMARSJOYWSJRUBYQTTQTNTPSTVPSTI.TAPSTIOMEXOCFTNHMVSTMNSON.MXMNSOMNOVMITOMATXLOVELMNRLCIKPLTKCK2CG34.SAIGCIWIGCEOSEWEOSEEFTREFOIDUODAON.MXDAOCYRNCYCNCTICCOSMCFRXCDTXCALABLCMBABAN.MXBABAFBABA.BABABAAXDX.MXAXDXAUVIPAUVIATHXANVSAMPEAHLA.DE9988.HK4875.T0VGI.L0H8E.LZIMRIGLREKRDBVTDBV.PASMGIMTEDDLBYSI0L45.L- Published at
- by benzinga.com
mixedmixed50 Stocks Moving In Wednesday's Mid-Day Session
Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) shares gained 81% to $1.8503 after the company authorized a $3.5 million buyback.